The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.
Many Indians with normal cholesterol reports may still face early heart disease due to a genetic marker called Lipoprotein(a). This cholesterol particle increases plaque buildup and clotting risk in ...
Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.
Hosted on MSN
THIS overlooked blood test could expose the real cause of heart attacks in people who seem perfectly healthy
Most health-conscious people closely track their cholesterol, blood sugar, and blood pressure, but cardiologists are now highlighting another vital yet often ignored heart health factor, Lipoprotein(a ...
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
The evidence implicating high levels of lipoprotein(a), or Lp(a), as a risk predictor for heart attack, stroke, and other cardiovascular conditions has outpaced the science of what to do about the ...
NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...
Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, ...
Hosted on MSN
The hidden cholesterol test that may reduce heart attack risk, according to a cardiologist
Worried about high cholesterol levels? Well, apart from taking a good diet, working out, and changing your lifestyle, here’s one thing doctors advise you to do, especially if you are in your early 30s ...
Please provide your email address to receive an email when new articles are posted on . A lipoprotein(a) assay received breakthrough device designation from the FDA. The assay is designed to aid in ...
A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results